Watson approved for generic Fentora
Watson Pharmaceuticals Inc. has received approval from the Food and Drug Administration for fentanyl buccal tablets, a pain reliever for cancer patients. The company said Monday that its Watson Laboratories Inc. subsidiary gained approval from the FDA for fentanyl buccal tablets in strengths of 0.